Columbia University Irving Medical Center
W25.1- Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ Triple) in Adolescents and Adults with CF: Results from Two Randomized, Active-Controlled Phase 3 Trials
Friday, September 27, 202410:15 AM – 12:15 PM ET